期刊文献+

序贯疗法治疗幽门螺杆菌感染患者疗效观察 被引量:2

The clinical observation of sequential therapy for patients with Helicobacter pylori infection
下载PDF
导出
摘要 目的观察序贯疗法治疗幽门螺杆菌(HP)感染患者的疗效。方法经胃镜检查确诊的慢性胃炎或消化性溃疡且HP阳性患者82例随机分为治疗组和对照组。治疗组(42例)方案为前5d奥美拉唑+阿莫西林,后5d奥美拉唑+克拉霉素+替硝唑;对照组(40例)三联疗法为奥美拉唑+阿莫西林+克拉霉素,疗程7d。结果治疗组Hp根除率92.85%,对照组Hp根除率75.00%,2组比较差异有统计学意义(P<0.05)。结论以奥美拉唑、阿莫西林、克拉霉素、替硝唑组成的10d序贯疗法治疗Hp感染较7d三联疗法有更高的根除率,可提高临床疗效。 Objective To study the effects of sequential therapy for H.pylori eradication.Methods 82 patients with HP positive chronic gastritis and peptic ulcer were randomly divided into two groups.42 patients were treated with Omeprazole,Amoxillin at first five days,Omeprazole,Clarithromycin and Tinidazole at the second five days.The control group(40 patients)were treated with Omeprazole,Amoxillin and Clarithromycin for seven days.Results The eradication rate of 10 d sequential therapy was 92.85%,and that of control group was 75.00%.The difference between two groups was significant(P0.05).Conclusion The sequential therapy is more efective and better treatment for H.pylori eradication.
出处 《中国实用医药》 2011年第22期46-47,共2页 China Practical Medicine
关键词 序贯疗法 幽门螺杆菌 慢性胃炎 消化性溃疡 Sequential therapy Helicobacter pylori Chronic gastritis Peptic ulcer
  • 相关文献

参考文献5

二级参考文献20

  • 1[3]JohnCA,Cao P,Richard MP,et al.Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori[J].J Bio Che,1995,270 (30):17771
  • 2[4]Mendonca S,Ecclissato C,Sartori MS,et al.Prevalence of Helicobacter pylori resistance to metronidazole,clarithromycin,amoxicillin,tetracycline,and furazolidone in Brazil[J].Helicobacter,2000,5(2):79
  • 3刘文忠 徐蔚文.幽门螺杆菌对甲硝唑及克拉霉素耐药率的变迁[A]..中华医学会第六次全国消化病学术会议论文摘要[C].西安,1999,10..
  • 4Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ ,2000,321: 659-664.
  • 5XiaoSD,LiuWZ,HuPJ,XiaDH,TytgatGNJ.HighcurerateofHelicobacterpyloriinfectionus-ingtripotassiumdicitratobismuthate,furazoli-doneandclarithromycintripletherapyfor1week.AlimentPharmacolTher,1999,13:311~315.
  • 6LiuWZ,XiaoSD,ShiY,WuSM,ZhangDZ,XuWW,TytgatGNJ.Furazolidone-containingshort-termtripletherapiesareeffectiveinthetreat-mentofHelicobacterpyloriinfection.AlimentPharmacolTher,1999,13:317~322.
  • 7LindT,MegraudF,UngeP,BayerdorfferE,O'morainC,SpillerR,VeldhuyzenVanZantenS,BardhanKD,HellblomM,WrangstadhM,ZeijlonL,CederbergC.TheMACH2study:roleofome-prazoleineradicationofHelicobacterpyloriwith1-weektripletherapies[seecomments].Gastroen-terology,1999,116:248~253.
  • 8vanderHulstRWM,KellerJJ,RauwsEA,TytgatGNJ.TreatmentofHelicobacterpyloriinfection:areviewoftheworldliterature.Helicobacter,1996,1:6~19.
  • 9WalshJH,PetersonWL.ThetreatmentofHelico-bacterpyloriinfectioninthemanagementofpep-ticulcerdisease[seecomments].NEnglJMed,1995,333:984~991.
  • 10BazzoliF,ZagariM,PozzatoP,VaroliO,FossiS,RicciardielloL,AlampiG,NicoliniG,SottiliS,SimoniP,RodaA,RodaE.Evaluationofshort-termlow-dosetripletherapyforeradicationofHe-licobacterpyloribyfactorialdesigninarado-mized,double-blindcontrolledstudy.AlimentPharmacolTher,1998,12:439~445.

共引文献134

同被引文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部